COVID-19 has had big impacts on big Pharma. Supply chains are tested by foreign sourcing of active ingredients (APIs), generics and vaccines. Clinical trials are hindered by stay at home orders. Potential vaccines and therapeutics are racing ahead, requiring fast trials and capacity ramp-up. Labs are strained by huge testing needs.
Many changes are underway. The U.S. contracted Phlow Corp. in Virginia to manufacture generics and APIs for COVID-19 that are now made overseas. J&J began the first virtual clinical trial in early 2020 for a heart treatment. Companies are seeking transparency on drug supplies worldwide, requiring more digital/analytics-based solutions, also looking to automate manufacturing and warehouse processes to cut staff needs and add data capture.
The future of Pharma is being written. You need to stay ahead of the game. MOSIMTEC’s Pharmaceutical simulation helps visualize workflows and make intelligent decisions in a complex matrix of processes and interconnected systems. You can explore options to ramp up lab and production capacity, speed up clinical trials, and optimize supply chain performance across multiple sites to balance risk, cost, lead time, other factors. Technology lights the way. MOSIMTEC is here to help.
#covid19 #supplychain #pharma #simulation